Etiology and Major Causes
There are three primary pathogenetic groups of factors leading to hyperkalemia:
- Decreased Renal Excretion. Healthy kidneys excrete quantities of potassium that significantly exceed daily intake. However, in renal impairment, hyperkalemia develops even with normal or reduced potassium intake. Another cause is hypoaldosteronism (due to adrenal insufficiency or decreased tubular epithelial sensitivity in amyloidosis, renal failure, and interstitial disease). This leads to impaired $Na^+$ reabsorption in the distal tubules, which disrupts the coupled excretion of $K^+$.
- Transcellular Shift (Intracellular to Extracellular). Observed during massive tissue damage and cell destruction: erythrocyte hemolysis, burns, crush injuries, ischemia, necrosis, and crush syndrome (compartment syndrome). Additionally, potassium efflux is stimulated by hypoinsulinemia (due to enhanced glycogenolysis and proteolysis) and intracellular acidosis, in which $K^+$ ions leave the cell while $Cl^-$ ions enter.
- Excessive Intake. Acute or chronic dietary hyperkalemia is extremely rare because intact kidneys efficiently eliminate excesses.
Clinical Manifestations
The clinical presentation of hyperkalemia is entirely driven by disruptions in the resting membrane potential (RMP), action potential generation, and impulse transmission at neuromuscular synapses.
Neuromuscular Disturbances Patients report muscle pain and marked weakness. Objective findings include muscle hypotonia, hyporeflexia, and in severe cases, flaccid paralysis. A characteristic visceral manifestation involving internal organs is intestinal atony.
Cardiovascular Manifestations The most critical clinical sign is the progressive loss of cardiomyocyte excitability alongside a significant increase in the heart's cholinoreactive properties. This results in bradycardia and severe arrhythmias. Atrioventricular and intraventricular blocks develop. At potassium levels of 8–10 mmol/L, complete heart block may occur, and at levels above 10 mEq/L, cardiac arrest in diastole ensues.
Management of Hyperkalemia
Emergency therapy involves three main approaches:
- Treat the Underlying Cause. Eliminating the primary etiological factor that triggered the electrolyte disturbance.
- Promote Intracellular Shift. Stimulating the transport of $K^+$ from the extracellular fluid back into cells. Intravenous administration of calcium chloride, sodium bicarbonate (which potentiates intracellular potassium uptake), or a combination of dextrose (glucose) and insulin is utilized. Insulin stimulates the co-transport of glucose and potassium into cells, rapidly reducing hyperkalemia and cardiotoxicity.
- Enhance Potassium Elimination. Treatments include hemodialysis (lowering potassium levels by half in 3–4 hours), loop diuretics (e.g., furosemide), and aldosterone analogs (deoxycorticosterone acetate). Cation-exchange resins (such as sodium polystyrene sulfonate) show high efficacy. Upon reaching the intestine—where potassium concentration is 2 to 4 times higher than in the blood—they bind and eliminate 60–100 mmol of the macroelement within the first 4–6 hours.